A proof-of-concept trial shows novel sarcoidosis PET/CT tracer detects inflammatory activity, supporting further clinical ...

The Foundation for Sarcoidosis Research (FSR) is proud to announce the release of its comprehensive Voice of the Patient report, capturing the powerful insights, lived experiences, and treatment ...

Patients with pulmonary sarcoidosis showed significantly higher uptake of the VAP-1–targeted PET tracer in the lungs and ...

Sarcoidosis is a condition involving the growth of persistent or inappropriate granulomas or clumps of inflammatory cells. For some people, symptoms will resolve on their own without needing treatment ...

The sarcoidosis community mourns Bernie Mac, who suffered from the disease. Aug. 17, 2008— -- For Andrea Wilson of Chicago, Valentine's Day 1994 marked the end of an eight-year search to identify ...

Pulmonary sarcoidosis is a condition that causes tiny groups of immune cells to clump in your lungs. These groups of cells form swollen, inflamed lumps called granulomas. Granulomas can make it hard ...

Please provide your email address to receive an email when new articles are posted on . Three environmental exposure clusters heightened the odds for sarcoidosis in African Americans. Environmental ...

See References Table 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org, for additional references pertaining to this table. An adverse prognosis indicates a ...

The symptoms of sarcoidosis vary significantly between patients due to the size, number, and location of the nodules that characterize the health condition. There may be one area of the body that is ...

This page lists all known medications that could potentially lead to 'Sarcoidosis' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published at the ATS 2025 International ...